BLS Polymers IPO 2026: Latest Update
BLS Polymers Limited is preparing to enter the Indian primary market with a ₹255 crore initial public offering. The IPO will open for subscription on October 27 and close on October 29, 2026.
The company plans to raise funds through a fresh issue of 1.70 crore equity shares, with no offer-for-sale component. The price band is ₹142 to ₹150 per share, and the shares are proposed to be listed on the BSE and NSE.
The proceeds will primarily support expansion of the company's existing manufacturing facility in Goa, working-capital requirements and general corporate purposes. The offering provides investors with an opportunity to participate in a specialised polymer-compounds manufacturer serving industrial customers.
BLS Polymers IPO Details
| Particular | Details |
|---|---|
| Company Name | BLS Polymers Limited |
| IPO Type | Mainboard IPO |
| IPO Open Date | October 27, 2026 |
| IPO Close Date | October 29, 2026 |
| Price Band | ₹142–₹150 per share |
| Face Value | ₹10 per share |
| Issue Size | ₹255 Crore |
| Fresh Issue | ₹255 Crore |
| Offer for Sale | Nil |
| Shares Offered | 1.70 Crore |
| Lot Size | 100 Shares |
| Minimum Investment | ₹15,000 at the upper price band |
| Listing Exchanges | BSE and NSE |
| Expected Allotment | October 30, 2026 |
| Expected Refund/Share Credit | November 2, 2026 |
| Expected Listing Date | November 3, 2026 |
| Registrar | KFin Technologies |
| Lead Manager | Unistone Capital |
BLS Polymers IPO GMP Today
The grey market premium for BLS Polymers IPO is unofficial and may vary between market trackers. Some reports published on October 20 indicated a premium of approximately ₹18 per share, while other platforms had not reported a confirmed GMP.
At an illustrative GMP of ₹18 and an upper issue price of ₹150, the implied price would be ₹168 per share. This is only an unofficial estimate, not a prediction or guaranteed listing price.
| Particular | Details |
|---|---|
| Upper IPO Price | ₹150 |
| Illustrative GMP | ₹18 |
| Indicative Price | ₹168 |
| Indicative Premium | 12% |
GMP figures can change quickly and are not regulated exchange prices. Investors should check the latest available figure before publishing or using it, and should not base an investment decision solely on grey-market activity.
BLS Polymers IPO Subscription Status
The BLS Polymers IPO has not opened for public bidding as of October 20, 2026. Therefore, live subscription figures for retail investors, non-institutional investors and qualified institutional buyers are not yet available.
The issue is scheduled to open on October 27. Once bidding begins, investors can follow the category-wise subscription data to understand demand relative to the shares available in each category.
Subscription numbers should be assessed alongside the company's valuation, financial performance and business risks rather than treated as a standalone measure of investment quality.
About BLS Polymers Limited
BLS Polymers Limited is an Indian manufacturer of specialised polymer compounds used in industrial and infrastructure applications. The company was incorporated in 1991 and operates a manufacturing facility in Goa.
Its products are used in the production of wires and cables, underground pipelines, power-transmission systems, telecommunications infrastructure and other industrial applications. The company develops customised compound formulations to meet the technical and performance requirements of customers.
BLS Polymers serves domestic industrial customers and has also expanded its export activities into markets including Saudi Arabia, the United Arab Emirates and Egypt. Its position in specialised compounds connects its business to demand from infrastructure, power, telecommunications and related industries.
BLS Polymers Product Portfolio
The company manufactures a range of polymer compounds designed for different applications and operating conditions.
Its product portfolio includes high-density polyethylene (HDPE), medium-density polyethylene (MDPE), linear low-density polyethylene (LLDPE), cross-linked polyethylene (XLPE), polyvinyl chloride (PVC), halogen-free flame-retardant compounds, cable-filling compounds and adhesive coating compounds.
These materials are used in cable insulation and sheathing, protective coatings and pipeline-related applications. Product specifications vary depending on the intended use, including electrical performance, durability, flame resistance and environmental requirements.
The company's ability to provide specialised formulations and meet customer quality standards is important in an industry where material consistency and technical specifications can influence purchasing decisions.
BLS Polymers Manufacturing Facility
BLS Polymers operates a manufacturing facility in Goa, where it produces different grades of polymer compounds for industrial customers.
The facility includes production machinery, quality-control capabilities and an in-house laboratory. These resources support product testing and the development of customised formulations for customer requirements.
The company plans to expand its existing manufacturing capacity using part of the IPO proceeds. Additional capacity could help it address customer demand and increase production capability, although the results will depend on execution, utilisation levels and market conditions.
BLS Polymers IPO Financial Performance
BLS Polymers reported growth in revenue and profitability in FY2026 compared with FY2025. Its financial performance is relevant for evaluating the company's ability to fund expansion and manage working-capital requirements.
| Particular | FY2025 | FY2026 |
|---|---|---|
| Revenue | ₹336.70 Cr | ₹354.41 Cr |
| Profit After Tax | ₹21.14 Cr | ₹27.01 Cr |
| EBITDA | ₹39.66 Cr | ₹46.60 Cr |
| Net Worth | ₹67.94 Cr | ₹94.93 Cr |
| Total Borrowings | ₹73.92 Cr | ₹51.72 Cr |
The figures indicate that revenue increased moderately while profit after tax and EBITDA improved more substantially in FY2026. Investors should also examine margins, operating cash flow, receivables, inventory and borrowing requirements to understand the quality and sustainability of that growth.
The company's financial performance should be considered over multiple periods, particularly because industrial manufacturers can be affected by raw-material prices, customer demand, capacity utilisation and payment cycles.
BLS Polymers IPO Objectives
The company intends to use the IPO proceeds for three principal purposes.
Expansion of manufacturing capacity: A portion of the funds will finance capital expenditure at the existing Goa manufacturing facility, including increasing the production capacity of selected products.
Working-capital requirements: Manufacturing businesses need funds to purchase raw materials, maintain inventory, process orders and manage the time between production and customer payments. IPO proceeds allocated to working capital can support these operating requirements.
General corporate purposes: The remaining permitted funds will be used for general corporate needs in accordance with the final offer documents.
The planned expansion could strengthen the company's production capabilities, but the actual benefits will depend on how efficiently the additional capacity is commissioned and utilised.
BLS Polymers IPO Market Opportunity
Demand for specialised polymer compounds is connected to several industrial sectors, including power transmission, telecommunications, water infrastructure, oil and gas, and underground pipeline networks.
As infrastructure projects expand, suppliers of cable and pipeline materials may benefit from increased demand for reliable and technically compliant products. The transition towards stronger electrical networks and improved connectivity can also create opportunities for specialised material manufacturers.
However, demand is not guaranteed to increase uniformly across all product categories. Competitive pricing, customer qualification requirements, input-cost movements and the pace of infrastructure spending can influence the company's performance.
BLS Polymers Export Business
BLS Polymers has expanded its international business, with exports reported to markets including Saudi Arabia, the United Arab Emirates and Egypt.
International sales can diversify a manufacturer's customer base and create opportunities beyond the domestic market. At the same time, export operations require compliance with customer specifications, delivery schedules and relevant market requirements.
Investors tracking the company's future performance can monitor export contribution, customer concentration and the consistency of overseas orders to understand how effectively it is developing its international business.
BLS Polymers IPO Valuation
At the upper price band of ₹150 per share, the reported post-issue market capitalisation is approximately ₹930 crore. The valuation should be considered alongside the company's earnings, debt position, growth prospects and capital requirements.
A company's valuation is not determined by revenue growth alone. Investors should also assess profit margins, earnings per share, return ratios and the price-to-earnings multiple relative to comparable listed businesses.
The IPO proceeds are intended to support expansion and working capital, so investors should also evaluate whether the proposed spending can generate sufficient future returns.
BLS Polymers IPO Risks
Before considering the issue, investors should review the risks disclosed in the company's offer documents.
-
Raw-material price fluctuations: Changes in polymer and other input costs can affect margins if higher costs cannot be passed on to customers.
-
Customer concentration: Dependence on a limited number of major customers or projects can make revenue less predictable.
-
Capacity-expansion execution: Delays, cost overruns or lower-than-expected utilisation could affect the benefits of the planned investment.
-
Working-capital requirements: Inventory and receivables can tie up funds and place pressure on cash flow.
-
Competition: Domestic and international manufacturers compete on pricing, product quality, technical capabilities and delivery.
-
Industrial demand cycles: Changes in infrastructure spending and customer purchasing patterns may affect order volumes.
Investors should read the risk factors in the final offer documents before applying.
BLS Polymers IPO Important Dates
| IPO Event | Expected Date |
|---|---|
| Anchor Investor Bidding | October 26, 2026 |
| IPO Opens | October 27, 2026 |
| IPO Closes | October 29, 2026 |
| Basis of Allotment | October 30, 2026 |
| Refund/Fund Unblocking | November 2, 2026 |
| Shares Credited to Demat | November 2, 2026 |
| Expected Listing | November 3, 2026 |
The dates above reflect the currently published IPO schedule and should be checked against official exchange updates.
BLS Polymers IPO: Key Points for Investors
BLS Polymers is entering the primary market with a ₹255 crore fresh issue, and its planned expansion is focused on increasing manufacturing capacity and supporting working capital. The company reported higher revenue, EBITDA and profit after tax in FY2026 compared with FY2025.
Investors should consider these developments alongside the company's valuation, raw-material exposure, working-capital needs, customer concentration and execution risks. The IPO's final subscription figures and any changes in GMP may provide additional market context, but neither guarantees positive listing performance.
BLS Polymers IPO Summary
BLS Polymers IPO is a mainboard public issue scheduled from October 27 to October 29, 2026, with a price band of ₹142–₹150 per share and an issue size of ₹255 crore.
The company manufactures specialised polymer compounds used in wires, cables, pipelines and other industrial applications. Its FY2026 results showed growth in revenue and profitability, while the IPO proceeds are intended to support manufacturing expansion and working capital.
With listing planned for November 3, 2026, the issue will be watched by investors interested in India's industrial-materials and infrastructure supply chain. The final decision to apply should be based on the offer documents, valuation, financial performance and individual risk tolerance rather than GMP alone.
Loading comments...